Obesity Drug Maker Faces Investor Suit Over IPO Disclosures

By Emilie Ruscoe · January 7, 2025, 11:10 PM EST

Biopharmaceutical company BioAge Labs Inc. is facing a proposed class action alleging investors in its initial public offering were hurt by plummeting share prices after the company unexpectedly hit the brakes...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re BioAge Labs, Inc., Securities Litigation

Case Number

3:25-cv-00196

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2025